Literature DB >> 35191502

RE: Cancer Stage, Treatment, and Survival Among Transgender Patients in the United States.

Juan Javier-DesLoges1, Amirali Salmasi1, Christina Am Jamieson1, Jennifer T Anger1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35191502      PMCID： PMC9360451          DOI： 10.1093/jnci/djac039

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   11.816


× No keyword cloud information.
  7 in total

1.  An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.

Authors:  Jindan Yu; Jianjun Yu; Ram-Shankar Mani; Qi Cao; Chad J Brenner; Xuhong Cao; Xiaoju Wang; Longtao Wu; James Li; Ming Hu; Yusong Gong; Hong Cheng; Bharathi Laxman; Adaikkalam Vellaichamy; Sunita Shankar; Yong Li; Saravana M Dhanasekaran; Roger Morey; Terrence Barrette; Robert J Lonigro; Scott A Tomlins; Sooryanarayana Varambally; Zhaohui S Qin; Arul M Chinnaiyan
Journal:  Cancer Cell       Date:  2010-05-18       Impact factor: 31.743

2.  NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.

Authors:  Peter R Carroll; J Kellogg Parsons; Gerald Andriole; Robert R Bahnson; Erik P Castle; William J Catalona; Douglas M Dahl; John W Davis; Jonathan I Epstein; Ruth B Etzioni; Thomas Farrington; George P Hemstreet; Mark H Kawachi; Simon Kim; Paul H Lange; Kevin R Loughlin; William Lowrance; Paul Maroni; James Mohler; Todd M Morgan; Kelvin A Moses; Robert B Nadler; Michael Poch; Chuck Scales; Terrence M Shaneyfelt; Marc C Smaldone; Geoffrey Sonn; Preston Sprenkle; Andrew J Vickers; Robert Wake; Dorothy A Shead; Deborah A Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2016-05       Impact factor: 11.908

3.  Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.

Authors:  David C Grossman; Susan J Curry; Douglas K Owens; Kirsten Bibbins-Domingo; Aaron B Caughey; Karina W Davidson; Chyke A Doubeni; Mark Ebell; John W Epling; Alex R Kemper; Alex H Krist; Martha Kubik; C Seth Landefeld; Carol M Mangione; Michael Silverstein; Melissa A Simon; Albert L Siu; Chien-Wen Tseng
Journal:  JAMA       Date:  2018-05-08       Impact factor: 56.272

Review 4.  Prostate cancer in transgender women.

Authors:  Matthew D Ingham; Richard J Lee; Dhara MacDermed; Aria F Olumi
Journal:  Urol Oncol       Date:  2018-10-12       Impact factor: 3.498

5.  Prostate cancer incidence in orchidectomised male-to-female transsexual persons treated with oestrogens.

Authors:  L Gooren; A Morgentaler
Journal:  Andrologia       Date:  2013-12-12       Impact factor: 2.775

6.  Clinical Utility of 4Kscore®, ExosomeDx™ and Magnetic Resonance Imaging for the Early Detection of High Grade Prostate Cancer.

Authors:  Claire M de la Calle; Vittorio Fasulo; Janet E Cowan; Peter E Lonergan; Martina Maggi; Adam J Gadzinski; Reuben Au Yeung; Alberto Saita; Matthew R Cooperberg; Katsuto Shinohara; Peter R Carroll; Hao G Nguyen
Journal:  J Urol       Date:  2020-09-08       Impact factor: 7.450

7.  Cancer Stage, Treatment, and Survival Among Transgender Patients in the United States.

Authors:  Sarah S Jackson; Xuesong Han; Ziling Mao; Leticia Nogueira; Gita Suneja; Ahmedin Jemal; Meredith S Shiels
Journal:  J Natl Cancer Inst       Date:  2021-09-04       Impact factor: 11.816
  7 in total
  1 in total

1.  Response to Javier-DesLoges, Salmasi, Jamieson, and Anger.

Authors:  Sarah S Jackson; Meredith S Shiels
Journal:  J Natl Cancer Inst       Date:  2022-08-08       Impact factor: 11.816
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.